Characterization of inhibition kinetics of (S)-warfarin hydroxylation by noscapine: implications in warfarin therapy.

about

The Noscapine Chronicle: A Pharmaco-Historic Biography of the Opiate Alkaloid Family and its Clinical Applications Noscapine recirculates enterohepatically and induces self-clearance.LC-MS-based metabolomics: an update.

P2860

Q26801133-BC2563F5-CEF6-40FA-9EC8-089CDC90BB91 Q35893886-91B92F1F-004A-44C3-BAD9-B2C0DF22A227 Q38202881-9064D804-95FF-4DEC-B4B4-0D17D4AA80DE

P2860

Characterization of inhibition kinetics of (S)-warfarin hydroxylation by noscapine: implications in warfarin therapy.

Item

http://www.wikidata.org/entity/Q37325594

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 17 September 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Characterization of inhibition ...... lications in warfarin therapy.

@en

Characterization of inhibition kinetics of

@nl

type

Item

label

Characterization of inhibition ...... lications in warfarin therapy.

@en

Characterization of inhibition kinetics of

@nl

prefLabel

Characterization of inhibition ...... lications in warfarin therapy.

@en

Characterization of inhibition kinetics of

@nl

P1476

Characterization of inhibition ...... lications in warfarin therapy.

@en

P2093

Hyunyoung Jeong

http://www.w3.org/2001/XMLSchema#string

Kent L Kunze

http://www.w3.org/2001/XMLSchema#string

Nan Zhang

http://www.w3.org/2001/XMLSchema#string

Ryan P Seguin

http://www.w3.org/2001/XMLSchema#string

Yan-Yan Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Crystal structure of human cytochrome P450 2C9 with bound warfarin

THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE

Prediction of in vivo drug-drug interactions from in vitro data: impact of incorporating parallel pathways of drug elimination and inhibitor absorption rate constant.

Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range.

Time-dependent inhibition (TDI) of CYP3A4 and CYP2C9 by noscapine potentially explains clinical noscapine-warfarin interaction.

Antitumor activity of Noscapine in combination with Doxorubicin in triple negative breast cancer.

The structure of human cytochrome P450 2C9 complexed with flurbiprofen at 2.0-A resolution.

Anticancer activity of Noscapine, an opioid alkaloid in combination with Cisplatin in human non-small cell lung cancer.

Risk assessment of mechanism-based inactivation in drug-drug interactions.

Metabolic map and bioactivation of the anti-tumour drug noscapine.

P304

2114-2123

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1124/DMD.113.053330

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256705755

http://www.w3.org/2001/XMLSchema#string

P698

24046330

http://www.w3.org/2001/XMLSchema#string

P932

3834133

http://www.w3.org/2001/XMLSchema#string

Characterization of inhibition kinetics of (S)-warfarin hydroxylation by noscapine: implications in warfarin therapy.

about

P2860

P2860

Characterization of inhibition kinetics of (S)-warfarin hydroxylation by noscapine: implications in warfarin therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932